Evidence map›Paper›PMID 34370762›Full record

ArticlePloS one2021

Level of non-adherence and its associated factors among adults on first-line antiretroviral therapy in Amhara Regional State, Ethiopia.

Setognal Birara Aychiluhm, Abay Woday Tadesse, Kusse Urmale Mare, Mequannent Sharew Melaku, Ibrahim Mohammed Ibrahim, Osman Ahmed, Oumer Abdulkadir Ebrahim, Mohammed Wagris, Yonatan Menber, Ayesheshim Muluneh Kassa

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Setognal Birara AychiluhmDepartment of Public Health, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.ORCID 0000-0001-7565-7515
Abay Woday TadesseDepartment of Public Health, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.
Kusse Urmale MareDepartment of Nursing, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.
Mequannent Sharew MelakuDepartment of Health Informatics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.ORCID 0000-0001-7348-8578
Ibrahim Mohammed IbrahimDepartment of Midwifery, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.
Osman AhmedDepartment of Nursing, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.
Oumer Abdulkadir EbrahimDepartment of Public Health, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.
Mohammed WagrisDepartment of Public Health, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.
Yonatan MenberDepartment of Public Health, College of Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Ayesheshim Muluneh KassaDream Science, and Technology College, Dessie, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Ethiopia, nearly one-third of people living with human immunodeficiency viruses do not adhere to antiretroviral therapy. Moreover, information regarding non-adherence and its associated factors among adults on first-line antiretroviral therapy in Northeast Ethiopia is limited. Therefore, this study aimed to assess the level of non-adherence and its associated factors among adults on first-line antiretroviral therapy in North Shewa Zone, Amhara Regional State, Ethiopia.

methodsA facility-based cross-sectional study was conducted on 326 participants selected by systematic random sampling technique from the five randomly selected public health facilities. Data were collected using the questionnaire adapted from the studies conducted previously and the collected data were entered into Epi data version 3.1 and exported to Stata version 14 for further analysis. Multivariable logistic regression analysis was done and an adjusted odds ratio with its corresponding 95% confidence interval was used to declare a statistical significance.

resultsThe overall prevalence of non-adherence was 17.4% [95% CI: (12.8%, 21.2%)]. Patients with no formal education [AOR (95% CI) = 5.57 (1.97, 15.88)], those who did not use memory aids to take their medications [AOR (95% CI) = 3.01 (1.27, 7.11)], travel more than 10 kilometers to visit the nearby antiretroviral therapy clinics [AOR (95% CI) = 2.42 (1.22, 25.86)], those who used substance [AOR (95% CI) = 3.57 (1.86, 28.69)], and patients whose medication time interfered with their daily routine activities [AOR (95% CI) = 15.46 (4.41, 54.28) had higher odds of having non-adherence to first-line antiretroviral therapy compared to their counter groups.

conclusionThe level of non-adherence to first-line antiretroviral therapy was 17.4%, higher compared to WHO's recommendation. Hence, patients counseling focused on avoiding substance use, use memory aids, and adjusting working time with medication schedule are very crucial. Furthermore, the ministry of health and the regional health bureau with other stakeholders should expand antiretroviral therapy service delivery at health facilities that are close to the community to address distance barriers.

Indexed as

Drug MonitoringHIV InfectionsAdolescentAdultAnti-HIV AgentsAnti-Retroviral AgentsCross-Sectional StudiesEthiopiaFemaleHumansMaleMiddle AgedSurveys and QuestionnairesYoung AdultAnti-HIV AgentsAnti-Retroviral Agents

Identifiers

PMID34370762
PMCPMC8351917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.